Screener
Healthcare Services Group HCSG Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 17.1%+6.2pp | 13.3%0.0pp | 13%-0.3pp | 12.5%-1.8pp | 10.9%-1.8pp | |
| Net margin | 6.6%+6.0pp | 3.7%+1.3pp | 3.2%+0.9pp | 2.2%-0.7pp | 0.6%-1.2pp | |
| Returns | ||||||
| Return on equity | 24.7%+22.4pp | 13.2%+4.8pp | 11.7%+3.4pp | 8.1%-2.7pp | 2.3%-4.4pp | |
| Return on invested capital | 37.2%+33.2pp | 18.7%+8.5pp | 16.2%+6.1pp | 11%-1.4pp | 4%-4.0pp | |
| Efficiency | ||||||
| Asset turnover | 2.3×+0.1× | 2.3×+0.1× | 2.3×+0.1× | 2.2×+0.1× | 2.2×+0.1× | |
| Liquidity | ||||||
| Current ratio | 3×+0.5× | 3.1×+0.2× | 3.4×+0.5× | 3×0.0× | 2.5×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -0.6×+1.0× | -1.3×-0.6× | -1.3×-0.7× | -1.4×-1.3× | -1.6×-1.5× | |
| Per Share | ||||||
| Book value per share | $7.42+13.8% | $7.23+4.0% | $6.99+3.4% | $6.80+2.8% | $6.52+2.1% | |
| Valuation | ||||||
| Market capitalization | $1.51B+49.4% | $1.3B+76.0% | $1.35B+58.2% | $1.22B+48.7% | $1.06B+35.9% | |
| Price / earnings | 12.3×-81.4× | 19.2×+1.3× | 22.8×+1.2× | 30.7×+14.3× | 97.9×+72.5× | |
| Price / sales | 0.8×+0.2× | 0.7×+0.3× | 0.7×+0.2× | 0.7×+0.2× | 0.6×+0.1× | |
| Price / book | 2.9×+0.8× | 2.5×+1.1× | 2.6×+0.9× | 2.5×+0.8× | 2.2×+0.6× | |
| EV / EBITDA | 8.4×-14.5× | 12.2×+3.4× | 14.3×+3.4× | 13.7×+4.9× | 24×+12.2× |
FAQ
- Where do Healthcare Services Group's ratios come from?
- Every ratio is computed from Healthcare Services Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
